Lucerastat
Product Specifications
CAS Number
141206-42-0
Target
Transferase
Related Pathways
Metabolism
Purity
0.98
Bioactivity
Lucerastat?NBDGJ? is an orally available inhibitor of Glucosylceramide Synthase (GCS) with therapeutic potential for Fabry disease. GCS is a key enzyme in sphingolipid synthesis and inhibition of its activity reduces the accumulation of harmful substrates.
Smiles
C(CCC)N1[C@H](CO)[C@H](O)[C@H](O)[C@@H](O)C1
Molecular Formula
C10H21NO4
Molecular Weight
219.28
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7168644 Inquire
Rabbit anti-Escherichia coli O9:H4 (strain HS) gltX Polyclonal Antibody
Ask
View Details 
NBP2-90388AF594 0.1 mL
Rabbit Monoclonal 4-1BB Ligand/TNFSF9 Antibody (014) [Alexa Fluor 594]
Ask
View Details 
MBS6134295-01 0.1 mL
TRAIP (TRAF-interacting Protein, TRIP, RING Finger Protein 206, RNF206) (AP)
Ask
View Details MBS6134295-02 5x 0.1 mL
TRAIP (TRAF-interacting Protein, TRIP, RING Finger Protein 206, RNF206) (AP)
Ask
View Details